v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net income (loss) $ 1,843 $ 4,836
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Investment related (gains) losses on sale of investments and other assets 510 486
Net deferred policy acquisition cost (8,661) (9,309)
Amortization of cost of insurance acquired 331 177
Depreciation 351 343
Amortization of premiums and discounts on investments 1,932 2,379
Stock-based compensation 1,009 1,797
Deferred federal income tax expense (benefit) (327) (375)
Change in:    
Accrued investment income (1,304) 23
Reinsurance recoverable (4,301) (2,447)
Due premiums 1,331 986
Future policy benefit reserves 1,907 (6,335)
Other policyholders' liabilities 13,206 14,670
Federal income tax receivable (377) (995)
Commissions payable and other liabilities (6,313) (1,417)
Other, net 587 (601)
Net cash provided by (used in) operating activities 1,724 4,218
Cash flows from investing activities:    
Purchases of fixed maturity securities, available-for-sale (53,373) (34,375)
Sales of fixed maturity securities, available-for-sale 16,569 14,569
Maturities and calls of fixed maturity securities, available-for-sale 28,365 14,723
Principal payments on mortgage loans 5 4
Change in policy loans 1,309 1,568
Sales of other long-term investments 2,601 2,031
Purchases of other long-term investments (1,547) (4,872)
Purchase of property and equipment (361) (283)
Net cash used in investing activities (6,432) (6,635)
Cash flows from financing activities:    
Annuity deposits 995 4,434
Annuity withdrawals (2,303) (8,345)
Other share repurchases 0 (272)
Net cash used in financing activities (1,308) (4,183)
Net increase (decrease) in cash and cash equivalents (6,016) (6,600)
Cash and cash equivalents at beginning of year 22,976 29,271
Cash and cash equivalents at end of period $ 16,960 $ 22,671